Andrew I. Koven
Mr. Koven is President and Chief Business Officer of Aralez Pharmaceuticals Inc. and served in this role with the company’s predecessor, POZEN Inc., since June 1, 2015. Mr. Koven has over 26 years of experience practicing law, most of which has been in the pharmaceutical industry. Prior to joining the company, Mr. Koven served as Executive Vice President, Chief Administrative Officer, and General Counsel and Secretary of Auxilium Pharmaceuticals, Inc. from February 2012 until its acquisition by Endo International plc in January 2015. In his role, Mr. Koven was responsible for Auxilium’s legal functions, government affairs and technical operations. Prior to Auxilium, Mr. Koven served as President and Chief Administrative Officer of Neurologix, Inc. Prior to that, Mr. Koven was Executive Vice President and Chief Administrative and Legal Officer at Inspire Pharmaceuticals, Inc., where he oversaw all matters related to legal, quality and compliance, corporate development and licensing and technical operations prior to the strategic acquisition of the company by Merck & Co. From 2007 to 2010 Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc. before its acquisition by Dainippon Sumitomo Pharma Co in 2009. Before joining Sepracor, Mr. Koven was Executive Vice President, General Counsel and Corporate Secretary at Kos Pharmaceuticals, Inc., where he oversaw the company’s legal, compliance and quality assurance departments until the acquisition of the company by Abbott Laboratories in 2006.